SCHEMBL13986324

SCHEMBL13986324

COC(=O)CNC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)C(O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 4/20 0.51
▸ AHCY P23526 4/20 0.48
▸ ADORA1 P30542 2/20 0.47
▸ ADORA2B P29275 2/20 0.47
▸ DPP4 P27487 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ SLC28A1 O00337 1/20 0.45
▸ MAP3K7 O43318 1/20 0.45
▸ SLC28A2 O43868 1/20 0.45
▸ GAPDH P04406 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ ADORA2A P29274 1/20 0.45
▸ STAT6 P42226 1/20 0.45
▸ PI4KA P42356 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ PI4K2B Q8TCG2 1/20 0.45
▸ DOT1L Q8TEK3 1/20 0.45
▸ SLC29A1 Q99808 1/20 0.45
▸ PI4K2A Q9BTU6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22220276 0.83 ADORA3 (0.61) ADORA3ADORA1ADORA2BDPP4MEN1
SCHEMBL22220139 0.83 ADORA3 (0.61) ADORA3ADORA1ADORA2BDPP4MEN1
SCHEMBL30446694 0.83 ADORA3 (0.61) ADORA3ADORA1ADORA2BDPP4MEN1
SCHEMBL21859283 0.83 ADORA3 (0.61) ADORA3ADORA1ADORA2BDPP4MEN1
SCHEMBL13773257 0.83 ADORA3 (0.61) ADORA3ADORA1ADORA2BDPP4MEN1
SCHEMBL21859152 0.83 ADORA3 (0.61) ADORA3ADORA1ADORA2BDPP4MEN1
SCHEMBL16812665 0.82 ADORA3 (0.47) ADORA3AHCYADORA1ADORA2BSMN1; SMN2
SCHEMBL13986326 0.82 ADORA1 (0.51) ADORA3AHCYADORA1ADORA2BDPP4
SCHEMBL13986329 0.82 ADORA1 (0.51) ADORA3AHCYADORA1ADORA2BDPP4
SCHEMBL4836541 0.82 ADORA1 (0.51) ADORA3AHCYADORA1ADORA2BDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465544-B2 Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-12-16 — — US disclosed
US-20070161007-A1 Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2007-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161007-A1 Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use DNMT1, MAT2A, MAT1A ADORA3 236/4885AHCY 6/4885ADORA1 294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback